Skip to main content

Jane Elizabeth Onken

Professor of Medicine
Medicine, Gastroenterology
Duke Box 3662, Durham, NC 27710
03137C Hosp South, Durham, NC 27710

Featured Works


Infliximab maintenance therapy for fistulizing Crohn's disease.

Journal article N Engl J Med · February 26, 2004 Featured Publication BACKGROUND: Infliximab, a monoclonal antibody against tumor necrosis factor, is an effective maintenance therapy for patients with Crohn's disease without fistulas. It is not known whether infliximab is an effective maintenance therapy for patients with fi ... Full text Link to item Cite

Mercaptopurine metabolite results in clinical gastroenterology practice.

Journal article Aliment Pharmacol Ther · January 2003 Featured Publication BACKGROUND: Azathioprine (AZA) and its active metabolite mercaptopurine (MP) are frequently used in the management of inflammatory bowel disease. Measurement of the AZA/MP metabolites, thioguanine (TG) and methylmercaptopurine (MMP), has been suggested as ... Full text Link to item Cite

Treatment patterns and costs associated with sessile colorectal polyps.

Journal article Am J Gastroenterol · November 2002 Featured Publication OBJECTIVES: Because of the paucity of existing literature on treatment and costs associated with sessile lesions, the objectives of this study were to perform a retrospective analysis on patients with sessile polyps to identify patient and polyp characteri ... Full text Link to item Cite

Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis.

Journal article Am J Gastroenterol · June 1998 Featured Publication OBJECTIVE: To illustrate the principles of cost-effectiveness analysis, this third article in the "Primer on Economic Analysis for the Gastroenterologist" applies published criteria for appraising an economic analysis to a study of the cost-effectiveness o ... Full text Link to item Cite

Manifestations of Crohn's disease.

Journal article Dig Dis · 1998 Featured Publication Full text Link to item Cite